Published • loading... • Updated
The Underhanded Tactics of Novo Nordisk and Eli Lilly to Sell Their Anti-Obesity Drugs
Summary by Reporterre, Le Quotidien De L'écologie…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Two manufacturers of anti-obesity treatments have been ordered to pay nearly €2 million for their deceptive advertising. Their aggressive and guilt-inducing marketing ignores environmental factors. "I've decided to take action, for myself and for my health." This is the message attributed to an overweight person in poster campaigns that appeared in the spring of 2025 and flooded the corridors of the Paris metro. Behind these advertisements, pres…
The Novo Nordisk and Eli Lilly laboratories are both subject to high financial penalties for their obesity awareness campaigns and treatments, and according to the Drug Safety Agency (ANSM), they are a disguised promotion of their medicines.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
